sc 51089 has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Northrop, NA; Yamamoto, BK | 1 |
| Alberch, J; Anglada-Huguet, M; Giralt, A; Martín, ED; Xifró, X; Zamora-Moratalla, A | 1 |
| Ahmad, AS; Dang, A; Doré, S; Greene, E; Leclerc, JL; Singh, N; Soshnik-Schierling, L | 1 |
| Ahmad, AS; Candelario-Jalil, E; DeMars, KM; Doré, S; Frankowski, JC; Hawkins, KE; Leclerc, JL; Yang, C | 1 |
| Fischborn, SV; Potschka, H; Soerensen, J | 1 |
| Applegate, R; Fathali, N; Jadhav, V; Khatibi, NH; Martin, R; Matus, B; Tang, J; Zhang, JH | 1 |
| Dobrowolski, P; Doré, S; Kapoor, N; Kim, YT; Langer, J; Li, RC; Maruyama, T; Narumiya, S; Yocum, J; Zhen, G | 1 |
| Anrather, J; Burmeister, MA; Cao, X; Davisson, RL; Guruju, MR; Iadecola, C; Peterson, JR; Wang, G; Young, CN | 1 |
8 other study(ies) available for sc 51089 and Disease Models, Animal
| Article | Year |
|---|---|
Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.
Topics: Analysis of Variance; Animals; Biogenic Monoamines; Body Temperature; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Hydrazines; Male; Methamphetamine; Oxazepines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2013 |
Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease.
Topics: Animals; Disease Models, Animal; Huntington Disease; Hydrazines; Male; Memory Disorders; Mice; Mice, Inbred CBA; Mice, Transgenic; Motor Skills Disorders; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype | 2014 |
Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor.
Topics: Animals; Astrocytes; Blood-Brain Barrier; Brain; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Gliosis; Hydrazines; Iron; Leukocytes; Male; Mice, Inbred C57BL; Microglia; Neuroimmunomodulation; Neuroprotective Agents; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Recovery of Function | 2015 |
Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
Topics: Animals; Blood-Brain Barrier; Brain Infarction; Disease Models, Animal; Endothelial Cells; Gene Expression; Gene Knockout Techniques; Hydrazines; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Neurons; Neutrophil Infiltration; Oxazepines; Permeability; Proteolysis; Rats; Receptors, Prostaglandin E, EP1 Subtype; Stroke; Tight Junction Proteins | 2015 |
Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice.
Topics: Amygdala; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Hydrazines; Kindling, Neurologic; Male; Mice; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype | 2010 |
Prostaglandin E2 EP1 receptor inhibition fails to provide neuroprotection in surgically induced brain-injured mice.
Topics: Animals; Brain Edema; Brain Injuries; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hydrazines; Male; Mice; Nervous System Diseases; Neuroprotective Agents; Neurosurgical Procedures; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Time Factors; Treatment Failure | 2011 |
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Brain; Brain Ischemia; Calcium; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glucose; Hippocampus; Humans; Hydrazines; Hypoxia; Male; Mice; Mice, Transgenic; Neurons; Neurotoxicity Syndromes; Oxazepines; Peptide Fragments; Presenilin-1; Receptors, Prostaglandin E, EP1 Subtype | 2012 |
Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain.
Topics: Angiotensin II; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Hydrazines; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxazepines; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Prostaglandin E, EP1 Subtype; Signal Transduction; Subfornical Organ | 2012 |